Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial
The aim was to analyze characteristics that predict remission induction and subsequent loss of remission in patients with moderately active rheumatoid arthritis (RA) who received full-dose combination etanerce...
Source: Arthritis Research and Therapy - Category: Rheumatology Authors: Josef S. Smolen, Annette Szumski, Andrew S. Koenig, Thomas V. Jones and Lisa Marshall Tags: Research article Source Type: research